Cargando…
Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
BACKGROUND: Angiosarcoma is an uncommon endothelial malignancy and a highly aggressive soft tissue sarcoma. Due to its infiltrative nature, successful management of localized angiosarcoma is often challenging. Systemic chemotherapy is used in the metastatic setting and occasionally in patients with...
Autores principales: | Florou, Vaia, Rosenberg, Andrew E., Wieder, Eric, Komanduri, Krishna V., Kolonias, Despina, Uduman, Mohamed, Castle, John C., Buell, Jennifer S., Trent, Jonathan C., Wilky, Breelyn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686562/ https://www.ncbi.nlm.nih.gov/pubmed/31395100 http://dx.doi.org/10.1186/s40425-019-0689-7 |
Ejemplares similares
-
Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
por: Florou, Vaia, et al.
Publicado: (2019) -
Emerging mechanisms of immunotherapy resistance in sarcomas
por: Florou, Vaia, et al.
Publicado: (2022) -
Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction
por: Florou, Vaia, et al.
Publicado: (2021) -
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
por: Florou, Vaia, et al.
Publicado: (2023) -
A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas
por: Espejo, Andrea P, et al.
Publicado: (2018)